Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides
- PMID: 23849563
- DOI: 10.1016/j.jaad.2013.04.063
Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides
Abstract
Background: Detailed rates of acute toxicity and skin infection during total skin electron beam therapy (TSEBT) for mycosis fungoides have not been reported in a large, modern series.
Objective: We sought to demonstrate the rates of acute toxicity and skin infection during TSEBT.
Methods: We retrospectively reviewed 89 consecutive courses of TSEBT. In all, 82 courses were prescribed a dose of 30 to 36 Gy and were included in the toxicity analysis. We recorded the types and grades of acute treatment toxicities and the incidence of infection during TSEBT for comparison with the previously documented baseline incidence of infection in mycosis fungoides.
Results: The most common toxicities included erythema/desquamation (76%), blisters (52%), hyperpigmentation (50%), and skin pain (48%). The worst reported toxicity grade per patient was grade 1 in 21%, grade 2 in 67%, and grade 3 in 10%, with no grade 4 or 5 toxicities. According to the previously reported rate, a total of 2.4 infections were expected for our cohort at baseline. The number with skin infection was 26 (32%) (relative risk 10.8, P < .01), and of these, 12 (15%) were culture confirmed (relative risk 5.0, P < .01).
Limitations: This was a retrospective study design.
Conclusion: The risk of cutaneous infection is significant during TSEBT.
Keywords: AJCC; American Joint Committee on Cancer; ECP; MF; OR; RT; TSEBT; extracorporeal photopheresis; infection; mycosis fungoides; odds ratio; race; radiation therapy; total skin electron beam therapy; toxicity.
Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Similar articles
-
Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.J Am Acad Dermatol. 2015 Feb;72(2):286-92. doi: 10.1016/j.jaad.2014.10.014. Epub 2014 Dec 2. J Am Acad Dermatol. 2015. PMID: 25476993
-
Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):987-95. doi: 10.1016/0360-3016(95)00073-8. Int J Radiat Oncol Biol Phys. 1995. PMID: 7607973
-
Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma.J Cancer Res Clin Oncol. 2021 Jun;147(6):1757-1761. doi: 10.1007/s00432-020-03449-7. Epub 2020 Nov 21. J Cancer Res Clin Oncol. 2021. PMID: 33219856 Free PMC article. Clinical Trial.
-
Total Skin Electron Beam Therapy in the Treatment of Mycosis Fungoides: A Review of Conventional and Low-Dose Regimens.Clin Lymphoma Myeloma Leuk. 2016 Dec;16(12):662-671. doi: 10.1016/j.clml.2016.08.019. Epub 2016 Aug 29. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27692530 Review.
-
Total skin electron beam therapy in mycosis fungoides-a shift towards lower dose?Chin Clin Oncol. 2019 Feb;8(1):9. doi: 10.21037/cco.2018.09.02. Epub 2018 Sep 17. Chin Clin Oncol. 2019. PMID: 30525748 Review.
Cited by
-
A simple solution to create a custom scalp-sparing helmet to prevent alopecia in patients undergoing total skin electron beam therapy for cutaneous T cell lymphoma.Clin Transl Radiat Oncol. 2022 Oct 17;38:53-56. doi: 10.1016/j.ctro.2022.10.005. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36388245 Free PMC article.
-
S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.J Dtsch Dermatol Ges. 2022 Apr;20(4):537-554. doi: 10.1111/ddg.14706. J Dtsch Dermatol Ges. 2022. PMID: 35446497 Free PMC article. No abstract available.
-
Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy.Clin Lymphoma Myeloma Leuk. 2020 Nov;20(11):757-767.e3. doi: 10.1016/j.clml.2020.06.020. Epub 2020 Jun 30. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32703750 Free PMC article.
-
Low-dose total skin electron beam therapy for cutaneous lymphoma : Minimal risk of acute toxicities.Strahlenther Onkol. 2017 Dec;193(12):1024-1030. doi: 10.1007/s00066-017-1188-8. Epub 2017 Aug 7. Strahlenther Onkol. 2017. PMID: 28785772 English.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical